Molecular basis of β thalassemia and potential therapeutic targets

SL Thein - Blood Cells, Molecules, and Diseases, 2018 - Elsevier
The remarkable phenotypic diversity of β thalassemia that range from severe anemia and
transfusion-dependency, to a clinically asymptomatic state exemplifies how a spectrum of …

Genetic modifiers of sickle cell disease

MH Steinberg, P Sebastiani - American journal of hematology, 2012 - Wiley Online Library
Sickle cell anemia is associated with unusual clinical heterogeneity for a Mendelian
disorder. Fetal hemoglobin concentration and coincident α thalassemia, both which directly …

[HTML][HTML] An integrated encyclopedia of DNA elements in the human genome

ENCODE Project Consortium - Nature, 2012 - ncbi.nlm.nih.gov
The human genome encodes the blueprint of life, but the function of the vast majority of its
nearly three billion bases is unknown. The Encyclopedia of DNA Elements (ENCODE) …

Pathophysiology and clinical manifestations of the β-thalassemias

AW Nienhuis, DG Nathan - Cold Spring …, 2012 - perspectivesinmedicine.cshlp.org
The β-thalassemia syndromes reflect deficient or absent β-globin synthesis usually owing to
a mutation in the β-globin locus. The relative excess of α-globin results in the formation of …

HBS1L-MYB intergenic variants modulate fetal hemoglobin via long-range MYB enhancers

R Stadhouders, S Aktuna, S Thongjuea… - The Journal of …, 2014 - Am Soc Clin Investig
Genetic studies have identified common variants within the intergenic region (HBS1L-MYB)
between GTP-binding elongation factor HBS1L and myeloblastosis oncogene MYB on …

Genomic approaches towards finding cis-regulatory modules in animals

RC Hardison, J Taylor - Nature Reviews Genetics, 2012 - nature.com
Differential gene expression is the fundamental mechanism underlying animal development
and cell differentiation. However, it is a challenge to identify comprehensively and accurately …

[HTML][HTML] Determinants of severity in sickle cell disease

DC Rees, VAM Brousse, JN Brewin - Blood Reviews, 2022 - Elsevier
Sickle cell disease is a very variable condition, with outcomes ranging from death in
childhood to living relatively symptom free into the 8 th decade. Much of this variability is …

Genetic variation at MECOM, TERT, JAK2 and HBS1L-MYB predisposes to myeloproliferative neoplasms

W Tapper, AV Jones, R Kralovics… - Nature …, 2015 - nature.com
Clonal proliferation in myeloproliferative neoplasms (MPN) is driven by somatic mutations in
JAK2, CALR or MPL, but the contribution of inherited factors is poorly characterized. Using a …

KLF1 mutations are relatively more common in a thalassemia endemic region and ameliorate the severity of β-thalassemia

D Liu, X Zhang, L Yu, R Cai, X Ma… - Blood, The Journal …, 2014 - ashpublications.org
Mutations in human Krüppel-like factor 1 (KLF1) have recently been reported to be
responsible for increased fetal hemoglobin (HbF) and hemoglobin A2 (HbA2). Because …

Variant-aware saturating mutagenesis using multiple Cas9 nucleases identifies regulatory elements at trait-associated loci

MC Canver, S Lessard, L Pinello, Y Wu, Y Ilboudo… - Nature …, 2017 - nature.com
Abstract Cas9-mediated, high-throughput, saturating in situ mutagenesis permits fine-
mapping of function across genomic segments. Disease-and trait-associated variants …